A Pilot Study Testing 1064nm Q-switch Laser Versus Glycolic Acid Peels for the Treatment of Melasma

Completed · Not applicable

Conditions studied: Melanosis

In brief

The purpose of this study is to find out the safety and effectiveness of 1064 Q-Switch Laser Therapy compared to Glycolic Acid Chemical Peels for the treatment of melasma.

Key facts

Study ID

NCT01976273

Run by

Northwestern University

People needed

20

Starts

2013-10-01

Expected to finish

2015-01-07

Last updated by the study team

2021-12-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects aged 18 years or older
• Subjects with at least a 2 x 2 cm patch of melasma on each side of the face (forehead or cheek)
• Subjects in general good health
• Subjects must be willing and able to understand and provide informed consent for the use of their tissue and communicate with the investigator
• Subjects must be willing to not apply other treatment options for melasma during the course of the study

You may not qualify if…

• Subjects under 18 years of age
• Subjects who are pregnant and/or lactating
• Subjects who are unable to understand the protocol or to give informed consent
• Subjects diagnosed with mental illness
• Subjects who have concurrent active uncontrolled disease to facial area (i.e uncontrolled acne)
• Subjects who have had a chemical peel in the past 3 months
• Subjects who have used a prescribed retinoid in the past 3 months
• Subjects with a bleeding disorder
• Subjects with a history of abnormal wound healing
• Subjects with a history of abnormal scarring
• Subjects who report being allergic to glycolic acid

Where it is running

• Northwestern University Department of Dermatology — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.